Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice

Inflammatory bowel disease (IBD) is one of the most common intestinal disorders, with increasing global incidence and prevalence. Numerous therapeutic drugs are available but require intravenous administration and are associated with high toxicity and insufficient patient compliance. Here, an oral l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xian, Shiyun, Zhu, Jiabin, Wang, Yuchen, Song, Haihan, Wang, Hangxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987780/
https://www.ncbi.nlm.nih.gov/pubmed/36861451
http://dx.doi.org/10.1080/10717544.2023.2183821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987780/
https://www.ncbi.nlm.nih.gov/pubmed/36861451
http://dx.doi.org/10.1080/10717544.2023.2183821

Ejemplares similares